4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-018609
General Counsel and Secretary gave up 2,360 shares (to pay taxes)
- General Counsel and Secretary acquired 5,084 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-10 | Option exercise | +2,834 | 46,539 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-11 | Shares withheld for taxes | −1,321 | $62.56 | $82,642 | 45,218 | D |
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-11 | Option exercise | +2,250 | 47,468 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-14 | Shares withheld for taxes | −1,039 | $61.08 | $63,462 | 46,429 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-10 | Option exercise · Restricted Stock Units | −2,834 | 2,833 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2022-03-11 | Option exercise · Restricted Stock Units | −2,250 | 6,750 | D | ||
Loading xslF345X03/doc4.xml…